We are live on ! Find out more
XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of XLRN yet.

XLRN Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Acceleron Pharma (XLRN) for Q1 2026, worth a combined $358 — unchanged from a quarter earlier.

Fund positioning in XLRN was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Acceleron Pharma (XLRN) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $358 of Acceleron Pharma stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Acceleron Pharma positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.